On Tuesday, Geron Corp (NASDAQ: GERN) was 5.00% up from the session before settling in for the closing price of $1.4. A 52-week range for GERN has been $1.09 – $4.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.60%. When this article was written, the company’s average yearly earnings per share was at 64.98%. With a float of $604.37 million, this company’s outstanding shares have now reached $637.85 million.
Geron Corp (GERN) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Geron Corp stocks. The insider ownership of Geron Corp is 5.27%, while institutional ownership is 76.75%. The most recent insider transaction that took place on May 09 ’25, was worth 15,667. In this transaction Director of this company bought 13,300 shares at a rate of $1.18, taking the stock ownership to the 13,300 shares. Before that another transaction happened on Feb 27 ’25, when Company’s EVP, Chief Legal Officer bought 15,000 for $1.61, making the entire transaction worth $24,150. This insider now owns 26,682 shares in total.
Geron Corp (GERN) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.04 earnings per share (EPS) during the time that was better than consensus figure (set at -0.08) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
You can see what Geron Corp (GERN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.01 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Looking closely at Geron Corp (NASDAQ: GERN), its last 5-days average volume was 5.43 million, which is a drop from its year-to-date volume of 12.34 million. As of the previous 9 days, the stock’s Stochastic %D was 38.89%.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 63.87%, which indicates a significant increase from 61.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0768 in the past 14 days, which was lower than the 0.0954 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3535, while its 200-day Moving Average is $2.1131. However, in the short run, Geron Corp’s stock first resistance to watch stands at $1.5300. Second resistance stands at $1.5900. The third major resistance level sits at $1.6600. If the price goes on to break the first support level at $1.4000, it is likely to go to the next support level at $1.3300. Should the price break the second support level, the third support level stands at $1.2700.
Geron Corp (NASDAQ: GERN) Key Stats
There are 638,017K outstanding shares of the company, which has a market capitalization of 937.88 million. As of now, sales total 76,990 K while income totals -174,570 K. Its latest quarter income was 49,040 K while its last quarter net income were -16,380 K.
